Looking at the biotech sector right now, new drug approvals could gain momentum in the wake of the FDA’s approval of Biogen’s Alzheimer’s drug, mergers… Read More »3 Outperforming Biotech Stocks With Further Upside In The Back Half Of 2021
“I believe that with the evidence of yesterday’s mergers, specifically the astoundingly well-priced purchase of Immunomedics (IMMU) by Gilead, that this is an area that… Read More »What Does “Merger Monday” Mean For Biotech?
The hottest stock-market sector may also be the best investment opportunity right now, both in terms of long-term returns and short-term gains. We’re talking about… Read More »“The Best Investment Opportunity Today”